FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4304758235> ?p ?o ?g. }

• W4304758235 endingPage "367" @default.
• W4304758235 startingPage "360" @default.
• W4304758235 abstract "Background Although live-attenuated vaccines are contraindicated under immunosuppression, the immune status of patients with inflammatory bowel disease (IBD) has not been fully assessed prior to immunosuppressive therapy.Aims To investigate antiviral serostatus against viruses requiring live vaccines for prevention in IBD patients undergoing immunosuppressive therapy.Methods This multicenter study included IBD patients who were aged <40 years and were treated with thiopurine monotherapy, molecular-targeted monotherapy, or combination therapy. Gender- and age-matched healthy subjects (HS) living in the same areas were included as control group. Antibody titers against measles, rubella, mumps, and varicella were measured by enzyme-linked immunosorbent assays.Results A total of 437 IBD patients (163 ulcerative colitis [UC] and 274 Crohn’s disease [CD]) and 225 HS were included in the final analysis. Compared with HS, IBD patients had lower seropositivity rates for measles (IBD vs. HS = 83.91% vs. 85.33%), rubella (77.55% vs. 84.89%), mumps (37.50% vs. 37.78%), and varicella (91.26% vs. 96.44%). Gender- and age-adjusted seropositivity rates were lower in UC patients than in both CD patients and HS for measles (UC, CD, and HS = 81.60%, 85.29%, and 85.33%), rubella (76.40%, 78.23%, and 84.89%), mumps (27.16%, 43.70%, and 37.78%), and varicella (90.80%, 91.54%, and 96.44%); the difference was significant for all viruses except measles. Divided by the degree of immunosuppression, there were no significant differences in seropositivity rates among IBD patients.Conclusions IBD patients, especially those with UC, exhibit reduced seropositivity rates and may benefit from screening prior to the initiation of immunosuppressive therapy." @default.
• W4304758235 created "2022-10-13" @default.
• W4304758235 creator A5005563820 @default.
• W4304758235 creator A5011529792 @default.
• W4304758235 creator A5017492890 @default.
• W4304758235 creator A5024854612 @default.
• W4304758235 creator A5033354312 @default.
• W4304758235 creator A5034412681 @default.
• W4304758235 creator A5040076561 @default.
• W4304758235 creator A5043020113 @default.
• W4304758235 creator A5044706381 @default.
• W4304758235 creator A5049356235 @default.
• W4304758235 creator A5053409025 @default.
• W4304758235 creator A5053573092 @default.
• W4304758235 creator A5056613279 @default.
• W4304758235 creator A5057393677 @default.
• W4304758235 creator A5057595877 @default.
• W4304758235 creator A5063199955 @default.
• W4304758235 creator A5066039132 @default.
• W4304758235 creator A5067907865 @default.
• W4304758235 creator A5068585362 @default.
• W4304758235 creator A5068594594 @default.
• W4304758235 creator A5071040721 @default.
• W4304758235 creator A5074097572 @default.
• W4304758235 creator A5074481547 @default.
• W4304758235 creator A5075561470 @default.
• W4304758235 creator A5078456062 @default.
• W4304758235 creator A5079586741 @default.
• W4304758235 creator A5080483009 @default.
• W4304758235 creator A5084236462 @default.
• W4304758235 creator A5088772727 @default.
• W4304758235 creator A5090676220 @default.
• W4304758235 date "2022-10-12" @default.
• W4304758235 modified "2023-09-26" @default.
• W4304758235 title "Reduced antiviral seropositivity among patients with inflammatory bowel disease treated with immunosuppressive agents" @default.
• W4304758235 cites W1967601069 @default.
• W4304758235 cites W2001136502 @default.
• W4304758235 cites W2012149683 @default.
• W4304758235 cites W2028315168 @default.
• W4304758235 cites W2042229410 @default.
• W4304758235 cites W2046595865 @default.
• W4304758235 cites W2056267203 @default.
• W4304758235 cites W2064333745 @default.
• W4304758235 cites W2121884639 @default.
• W4304758235 cites W2298630271 @default.
• W4304758235 cites W2516790154 @default.
• W4304758235 cites W2571140916 @default.
• W4304758235 cites W2791923916 @default.
• W4304758235 cites W2809392925 @default.
• W4304758235 cites W2897245366 @default.
• W4304758235 cites W2904413696 @default.
• W4304758235 cites W2946345857 @default.
• W4304758235 cites W2954304675 @default.
• W4304758235 cites W2972986676 @default.
• W4304758235 cites W2976362764 @default.
• W4304758235 cites W2979728042 @default.
• W4304758235 cites W2997937735 @default.
• W4304758235 cites W2999084747 @default.
• W4304758235 cites W3036385531 @default.
• W4304758235 cites W3081889650 @default.
• W4304758235 cites W3137785750 @default.
• W4304758235 cites W3158750369 @default.
• W4304758235 cites W3211135479 @default.
• W4304758235 cites W3212692368 @default.
• W4304758235 cites W4210350488 @default.
• W4304758235 cites W4210365593 @default.
• W4304758235 cites W4294755675 @default.
• W4304758235 doi "https://doi.org/10.1080/00365521.2022.2132831" @default.
• W4304758235 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36222610" @default.
• W4304758235 hasPublicationYear "2022" @default.
• W4304758235 type Work @default.
• W4304758235 citedByCount "0" @default.
• W4304758235 crossrefType "journal-article" @default.
• W4304758235 hasAuthorship W4304758235A5005563820 @default.
• W4304758235 hasAuthorship W4304758235A5011529792 @default.
• W4304758235 hasAuthorship W4304758235A5017492890 @default.
• W4304758235 hasAuthorship W4304758235A5024854612 @default.
• W4304758235 hasAuthorship W4304758235A5033354312 @default.
• W4304758235 hasAuthorship W4304758235A5034412681 @default.
• W4304758235 hasAuthorship W4304758235A5040076561 @default.
• W4304758235 hasAuthorship W4304758235A5043020113 @default.
• W4304758235 hasAuthorship W4304758235A5044706381 @default.
• W4304758235 hasAuthorship W4304758235A5049356235 @default.
• W4304758235 hasAuthorship W4304758235A5053409025 @default.
• W4304758235 hasAuthorship W4304758235A5053573092 @default.
• W4304758235 hasAuthorship W4304758235A5056613279 @default.
• W4304758235 hasAuthorship W4304758235A5057393677 @default.
• W4304758235 hasAuthorship W4304758235A5057595877 @default.
• W4304758235 hasAuthorship W4304758235A5063199955 @default.
• W4304758235 hasAuthorship W4304758235A5066039132 @default.
• W4304758235 hasAuthorship W4304758235A5067907865 @default.
• W4304758235 hasAuthorship W4304758235A5068585362 @default.
• W4304758235 hasAuthorship W4304758235A5068594594 @default.
• W4304758235 hasAuthorship W4304758235A5071040721 @default.
• W4304758235 hasAuthorship W4304758235A5074097572 @default.
• W4304758235 hasAuthorship W4304758235A5074481547 @default.
• W4304758235 hasAuthorship W4304758235A5075561470 @default.
• W4304758235 hasAuthorship W4304758235A5078456062 @default.

• next